Document Detail

Antibiotic treatment for urinary tract infections: pharmacokinetic/pharmacodynamic principles.
MedLine Citation:
PMID:  15566335     Owner:  NLM     Status:  MEDLINE    
Bacterial urinary tract infections (UTIs) frequently occur in the outpatient as well as in the nosocomial setting. The stratification into uncomplicated and complicated UTIs has proven to be clinically useful. Bacterial virulence factors on the one hand, and the integrity of the host defense mechanisms on the other, determine the course of the infection. Late complications or sequelae might ensue if the defense mechanisms are disturbed, either by a genetic or an acquired cause. Escherichia coli is the most prevalent organism in uncomplicated UTIs, whereas the bacterial spectrum is much broader in complicated UTIs, including Gram-negative and -positive, and often multiresistant organisms. Therapy for uncomplicated UTIs is almost exclusively antibacterial, whereas in complicated UTIs the complicating factors need to be treated as well. The success of antibiotic therapy of UTIs in a population can be estimated by four parameters: the minimal inhibitory concentrations of the clinical isolates, the pharmacokinetic and pharmacodynamic profiles, and the protein binding of the treatment drug. In uncomplicated UTIs, antimicrobial therapy is usually empiric, whereas in complicated UTIs antibiotic therapy should be more individualized; tailored to the individual patient.
Florian M E Wagenlehner; Kurt G Naber
Related Documents :
6981175 - Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in gr...
16107985 - Overview of nosocomial infections caused by gram-negative bacilli.
4599125 - Clinical study of the use of the new aminoglycoside tobramycin for therapy of infection...
8741235 - Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and ther...
24169385 - Agreement between serology and histology for detection of helicobacter pylori infection.
3619435 - Combined antiviral effects of acyclovir or bromovinyldeoxyuridine and human immunoglobu...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert review of anti-infective therapy     Volume:  2     ISSN:  1478-7210     ISO Abbreviation:  Expert Rev Anti Infect Ther     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2004-11-29     Completed Date:  2005-04-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  101181284     Medline TA:  Expert Rev Anti Infect Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  923-31     Citation Subset:  IM    
Hospital St Elisabeth Straubing, Urologic Clinic, St Elisabeth Str. 23, D-94315 Straubing, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Infective Agents, Urinary / administration & dosage,  pharmacology,  therapeutic use*
Cystitis / drug therapy
Practice Guidelines as Topic
Pyelonephritis / drug therapy
Urinary Tract Infections / classification,  drug therapy*,  microbiology
Reg. No./Substance:
0/Anti-Infective Agents, Urinary

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evolving issues in understanding and treating bacterial vaginosis.
Next Document:  Group counseling for mothers after emergency cesarean section: a randomized controlled trial of inte...